Track topics on Twitter Track topics that are important to you
Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group is co-hosting the seminar, “Insiders’ Views of Deal Making in the Life Sciences Sector,” with German biotech strategy consulting firm, Catenion.
TOKYO (PRWEB) October 22, 2019
Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group is co-hosting the seminar, “Insiders’ Views of Deal Making in the Life Sciences Sector,” with German biotech strategy consulting firm, Catenion. The seminar will take place from 16:00 – 18:00 p.m. on Oct. 25, 2019, at Greenberg Traurig’s Tokyo office.
Speakers from Greenberg Traurig and Catenion will discuss best practices and practical tips in deal making, as well as pitfalls in M&A, licensing, joint ventures, and strategic collaborations. Presentations will be followed by a panel discussion about recent trends and challenges involving international deal-making in the life sciences sector.
Co-chair of Greenberg Traurig’s Japan Practice Koichiro Ohashi will deliver the program's opening remarks. Other speakers include:
David J. Dykeman, patent attorney and co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and the Boston Intellectual Property & Technology (IP) Group
Wayne H. Elowe, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and co-chair of the firm’s Corporate Group in Atlanta
Christian Elze, senior partner and founder, Catenion GmbH
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Tokyo Office: Greenberg Traurig’s Tokyo office comprises an award-winning team of attorneys and professionals, who provide multinational and Japanese clients with innovative, strategic advice and legal services in a market known as a gateway to international business opportunities. Utilizing an understanding of the local culture and practical aspects of Japanese business, the firm’s multidimensional team offers custom strategies to fulfill client needs.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.
For the original version on PRWeb visit: https://www.prweb.com/releases/greenberg_traurig_s_tokyo_office_presents_insiders_views_of_deal_making_in_the_life_sciences_sector/prweb16666620.htmNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...